Literature DB >> 10223945

In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

J Guarro1, I Pujol, E Mayayo.   

Abstract

In the treatment of disseminated Fusarium infections, amphotericin B either alone or in combination with flucytosine and rifampin is the drug therapy most frequently used. The efficacy of these antifungal drugs was evaluated in a murine disseminated-infection model, with five strains of Fusarium solani. All the treatments were clearly ineffective.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10223945      PMCID： PMC89252     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens.

Authors:  N A Rotowa; H J Shadomy; S Shadomy
Journal:  Mycoses       Date:  1990-04       Impact factor: 4.377

2.  Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.

Authors:  A Reuben; E Anaissie; P E Nelson; R Hashem; C Legrand; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.

Authors:  F C Odds; F Van Gerven; A Espinel-Ingroff; M S Bartlett; M A Ghannoum; M V Lancaster; M A Pfaller; J H Rex; M G Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  Lack of activity of amphotericin B in systemic murine fusarial infection.

Authors:  E J Anaissie; R Hachem; C Legrand; P Legenne; P Nelson; G P Bodey
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

5.  In vitro antibiotic synergism against ocular fungal isolates.

Authors:  G A Stern
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

6.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

7.  The emerging role of Fusarium infections in patients with cancer.

Authors:  E Anaissie; H Kantarjian; J Ro; R Hopfer; K Rolston; V Fainstein; G Bodey
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

Review 8.  Amphotericin B: 30 years of clinical experience.

Authors:  H A Gallis; R H Drew; W W Pickard
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

9.  In vitro sensitivity of medically significant Fusarium species to various antimycotics.

Authors:  A S Sekhon; A A Padhye; A K Garg; H Ahmad; N Moledina
Journal:  Chemotherapy       Date:  1994 Jul-Aug       Impact factor: 2.544

10.  In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.

Authors:  M H Nguyen; F Barchiesi; D A McGough; V L Yu; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
View more
  11 in total

1.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

2.  Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex.

Authors:  Mónica Azor; Josepa Gené; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

3.  Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis.

Authors:  Michail S Lionakis; Georgios Chamilos; Russell E Lewis; Nathan P Wiederhold; Issam I Raad; George Samonis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient.

Authors:  J Guarro; M Nucci; T Akiti; J Gené
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi.

Authors:  J Capilla; M Ortoneda; F J Pastor; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

6.  Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.

Authors:  Mery Ruíz-Cendoya; Marçal Mariné; M M Rodríguez; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

7.  Pentamidine is active in vitro against Fusarium species.

Authors:  Michail S Lionakis; Russell E Lewis; George Samonis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis.

Authors:  W E Sponsel; J R Graybill; H L Nevarez; D Dang
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

Review 9.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

10.  Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.

Authors:  Montserrat Ortoneda; Javier Capilla; Francisco J Pastor; Isabel Pujol; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.